Patent application number | Description | Published |
20090062778 | Medical System Comprising Dual-Purpose Communication Means - The present invention relates to secure paring of electronically controlled devices adapted to communicate with each other. Thus, a medical system is provided comprising a first unit and a second unit, the system comprising first means of communication allowing a first group of data types to be transmitted between the first unit and the second unit, the first unit comprising an acoustic transducer having a transducer coil with a plurality of windings, the transducer coil serving as an antenna for wireless signals transmitted between the first and second units. In this way a “par-=asite” property of the acoustic transducer can be used, i.e. using the coil as a receiving means, thereby replacing a receiving structure, e.g. a separate receiver coil or an antenna, which would otherwise have to be provided, this reducing manufacturing costs. | 03-05-2009 |
20090069868 | Secure Pairing of Electronic Devices using Dual Means of Communication - The present invention relates to secure paring of electronically controlled devices adapted to communicate with each other. Thus, a medical system is provided comprising a first unit and a second unit, the system comprising first means of communication allowing a first group of data types to be transmitted between the first unit and the second unit, and second means of communication allowing a second group of data types to be transmitted between the first unit and the second unit. In this way different properties of the two means of communication can be used to secure that certain data, e.g. during pairing of the two devices, can be transmitted in a more controlled way whereas other data can be transmitted in a less controlled way. | 03-12-2009 |
20100030092 | Adaptive Hypoglycaemia Alert System and Method - The onset or presence of a hypoglycaemic condition in a living being is estimated by obtaining ECG signals, which are processed together with secondary input, such as skin impedance, information about a condition of the living being, or blood glucose level, to estimate whether the living being is experiencing or approaching a hypoglycaemic condition. An output alert may be generated. Feedback indicative of a possible misestimate of the onset or presence of the hypoglycaemic condition is received to allow a system incorporating the invention to adapt and personalize to a specific living being. The feedback may influence one or more sensitivity or specificity settings. Settings of the system may be influenced by the location or rate of movement of the living being. | 02-04-2010 |
20100145262 | SAFETY SYSTEM FOR INSULIN DELIVERY ADVISORY ALGORITHMS - A closed loop control system for a medical drug delivery device logs historical data such as drug delivered and corresponding physiological parameters such as blood glucose level. On the basis of the logged historical data, the system calculates an estimated event forecast on which basis the system further calculates the necessary, prudent future drug delivery profile in order to counter delay in the closed loop. The estimated event forecast is presented to the user, the user is thereby given the possibility to accept, reject or adjust the event forecast and the corresponding drug delivery profile. Dynamic and adaptive safety limits to the drug delivery and the physiological parameter can be set by the user and will dynamically follow the drug delivery profile and the event forecast and will further optimize based on the learned behavioural pattern of the user. The user can set the safety level as a percentage of deviation to the drug delivery profile. | 06-10-2010 |
20130172695 | Medical Skin Mountable Device and System - A medical device is provided comprising a transcutaneous device unit and a process unit. The transcutaneous device unit may comprise a transcutaneous device for transporting a fluid through a skin portion of a subject, and a mounting surface adapted for application to the skin of the subject. The process unit may comprise a reservoir adapted to contain a fluid drug, the reservoir comprising an outlet means allowing the transcutaneous device to be arranged in fluid communication with an interior of the reservoir, and an expelling assembly for expelling a fluid drug out of the reservoir and through the skin of the subject via the transcutaneous device. The transcutaneous device unit and the process unit further comprise coupling means allowing the reservoir unit to be secured to the transcutaneous device unit in the situation of use. By this arrangement a two-unit system is provided which can be used in a convenient and cost-effective manner. | 07-04-2013 |
20140094743 | System for Optimizing a Patient's Drug Dosage Regimen Over Time - A system for optimizing a patient's basal insulin dosage regimen over time, adapted to (a) determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and (b) at the same time display blood glucose value data and the recommended amount data as a function of time. | 04-03-2014 |
20140200545 | SYSTEM FOR OPTIMIZING A DRUG DOSAGE REGIMEN OVER TIME - A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value. | 07-17-2014 |
20140336586 | Drug Filled Delivery Assembly - A drug delivery assembly comprises a housing ( | 11-13-2014 |
20140371682 | Adaptive System for Optimizing a Drug Dosage Regimen Over Time - A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value. | 12-18-2014 |